课题基金 / 基金详情

Investigation of Brain Nitrogen Metabolism in Partial Ornithine Trascarbamylase

Investigation of Brain Nitrogen Metabolism in Partial Ornithine Trascarbamylase
部分鸟氨酸转氨甲酰酶脑氮代谢的研究
批准号:
8325108
负责人:
MARK L. BATSHAW
金额:
$8.29万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2014-07-31

项目摘要

项目成果

MARK L. BATSHAW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to validate brain biochemical, white matter and neuropsychological biomarkers that correlate with the effect of hyperammonemia on the brain in subjects with partial ornithine transcarbamylase deficiency (OTCD). We will use neuroimaging (1H MRS [magnetic resonance spectroscopy], DTI [diffusion tensor imaging], and fMRI [functional magnetic resonance imaging]) and neuropsychological testing to realize this goal. This proposed research represents a continuation and expansion of a cross sectional imaging study (RDCRN 5104) performed by this consortium that has identified elevations in brain glutamine (gin) and reductions of myoinositol (ml) as specific biomarkers in patients with OTCD. We will further study the relationship of these biomarkers under three conditions of nitrogen load: 1) during and following a hyperammonemic episode; 2) at clinical and metabolic stability; 3) following an infusion of a nitrogen scavenging agent (Ammonul). Our working hypothesis is that gin and ml are related to one another in the pathophysiology of hyperammonemia (HA) in OTCD. We propose that acute brain gin elevations herald acute HA. We further hypothesize that this biochemical alteration is followed by osmotic changes in the white matter detected by depletion in ml and changes of DTI. Lastly, we propose that chronic gin elevations will be seen in subjects with partial OTCD and that the severity of biomarker deviation will correlate with clinical severity. By studying the effects of the magnitude of change in gin and ml independently and in relationship to one another, we will strengthen the hypothesis that they are dependent variables and as such can be used as reliable biomarkers to follow clinical course, and be useful in development of novel therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rare Disease Clinical Research Training Program
  • 批准号:
    10489961
  • 项目类别:
  • 资助金额:
    $16.15万
  • 财政年份:
    2022
  • 负责人:
    MARK L. BATSHAW
  • 依托单位:
Career Development
  • 批准号:
    8858730
  • 项目类别:
  • 资助金额:
    $8.6万
  • 财政年份:
    2014
  • 负责人:
    MARK L. BATSHAW
  • 依托单位:
Longitudinal Study of Urea Cycle Disorders
  • 批准号:
    8858722
  • 项目类别:
  • 资助金额:
    $74.17万
  • 财政年份:
    2014
  • 负责人:
    MARK L. BATSHAW
  • 依托单位:
Biomarkers of Neurological Injury and Recovery in Urea Cycle Disorders
  • 批准号:
    8858723
  • 项目类别:
  • 资助金额:
    $10.01万
  • 财政年份:
    2014
  • 负责人:
    MARK L. BATSHAW
  • 依托单位:
海外基金